AngioDynamics ANGO Ratios & Valuation
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 54.3%-0.3pp | 54.6%+0.4pp | 54.1%+0.2pp | 53.9%-0.4pp | 54.4%+1.6pp | |
| Operating margin | -11.3%-0.7pp | -10.6%+1.9pp | -12.5%+1.2pp | -13.7%+3.5pp | -17.2%+66.1pp | |
| Net margin | -10%-1.0pp | -9%+1.7pp | -10.7%+0.9pp | -11.6%+3.0pp | -14.6%+63.8pp | |
| Returns | ||||||
| Return on equity | -17.5%-2.2pp | -15.3%+1.8pp | -17.1%+0.4pp | -17.5%+3.0pp | -20.5%+56.0pp | |
| Return on invested capital | -24.4%-1.2pp | -23.2%+2.4pp | -25.6%+3.7pp | -29.3%+3.9pp | -33.2%+65.7pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.1× | 1.1×0.0× | 1.1×+0.1× | 1×+0.1× | 0.9×+0.2× | |
| Liquidity | ||||||
| Current ratio | 2.4×+0.1× | 2.2×-0.1× | 2.3×+0.1× | 2.2×0.0× | 2.2×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0.1×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $4.17-1.8% | $4.24-2.3% | $4.34-3.0% | $4.48-1.6% | $4.55-0.3% | |
| Valuation | ||||||
| Market capitalization | $564.42M+38.7% | $510.88M+22.5% | $416.9M+5.7% | $394.29M+4.9% | $375.93M+33.5% | |
| Price / sales | 1.8×+0.4× | 1.7×+0.3× | 1.4×0.0× | 1.3×0.0× | 1.3×+0.3× | |
| Price / book | 3.3×+1.0× | 2.9×+0.6× | 2.3×+0.2× | 2.2×+0.1× | 2×+0.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AngioDynamics's profit margins?
- AngioDynamics (ANGO) runs a 54.3% gross margin and a -11.3% operating margin, with a -10.0% net margin.
- Where do AngioDynamics's ratios come from?
- Every ratio is computed from AngioDynamics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
